EUVIMEDEUVIMED entdecken
Crossref

A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial

Etienne Minvielle, Henri Leleu, Marc Masseti, Arlindo Ferreira, Gérard de Pouvourville, Mario Di Palma, Florian Scotté

The European Journal of Health Economics · 2025

DOI: 10.1007/s10198-024-01702-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Etienne Minvielle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gustave Roussy, Division of Interdisciplinary Patient Care Pathways (DIOPP), Villejuif, France. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Resilience, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsAgedFemaleHumansMaleMiddle AgedAdministration, OralBudgetsCost SavingsCost-Benefit AnalysisFranceMonitoring, PhysiologicQuality of LifeTelemedicineClinical Trials, Phase III as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Budget impact analysisCancer careCost savingsMedical resource utilizationRemote patient monitoring

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Gustave Roussy, Division of Interdisciplinary Patient Care Pathways (DIOPP), Villejuif, France.
  • I3-CRG, Ecole polytechnique -CNRS (French National Centre for Scientific Research), Institut polyetchnique de Paris, Palaiseau, France.
  • Public health expertise, 10 boulevard de Sébastopol, Paris, 75004, France. henri.leleu@ph-expertise.com.
  • Public health expertise, 10 boulevard de Sébastopol, Paris, 75004, France.
  • Resilience, Paris, France.
  • Católica Medical School, Universidade Católica Portuguesa, Lisbon, Portugal.

Förderung

  • Resilience, France

Zitieren

APA

Minvielle, E., Leleu, H., Masseti, M., Ferreira, A., de Pouvourville, G., Palma, M. D., & Scotté, F. (2025). A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial. The European Journal of Health Economics. https://doi.org/10.1007/s10198-024-01702-1

Vancouver

Minvielle E, Leleu H, Masseti M, Ferreira A, de Pouvourville G, Palma MD, et al. A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial. The European Journal of Health Economics. 2025. doi:10.1007/s10198-024-01702-1

BibTeX
@article{Minvielle2025,
  author = {Minvielle, Etienne and Leleu, Henri and Masseti, Marc and Ferreira, Arlindo and de Pouvourville, Gérard and Palma, Mario Di and Scotté, Florian},
  title = {A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial},
  journal = {The European Journal of Health Economics},
  year = {2025},
  doi = {10.1007/s10198-024-01702-1}
}
Kostenlos starten →